Summary of Study ST003361

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002087. The data can be accessed directly via it's Project DOI: 10.21228/M8V825 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003361
Study TitleBile acid–induced gut mitochondrial dysfunction promotes Enterobacteriaceae colonization and associates with dysbiosis in Crohn's disease
Study SummaryHere, we investigated whether bile acids influence gut colonization by Enterobacteriaceae. In an external human dataset, we found association between mucosal Enterobacteriaceae and the expression of mitochondrial damage–related genes. In a murine model, increased intestinal BA availability enhanced colonization by E. coli in an oxygen-dependent manner. Overall, this study establishes BAs as a potential bridge that facilitates interactions between commensals and the host epithelium, laying the essential foundation for future investigations into various intestinal diseases.
Institute
University of British Columbia
Last NameFinlay
First NameBrett
Addressoffice: MSL 333 lab: MSL 363
Emailbfinlay@msl.ubc.ca
Phone604-822-2210
Submit Date2024-07-30
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2024-08-05
Release Version1
Brett Finlay Brett Finlay
https://dx.doi.org/10.21228/M8V825
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002087
Project DOI:doi: 10.21228/M8V825
Project Title:Bile acid–induced gut mitochondrial dysfunction promotes Enterobacteriaceae colonization and associates with dysbiosis in Crohn's disease
Project Summary:Members of the Enterobacteriaceae family of bacteria are often overrepresented in inflammatory bowel disease (IBD). Bile acids (BAs) are cholesterol derivatives that are known to affect the growth of potentially pathogenic commensals (pathobionts), including those from the Enterobacteriaceae family. Furthermore, BAs are often increased in the colonic lumen of IBD patients, including patients with Crohn’s disease (CD). Here, we investigated whether bile acids influence gut colonization by Enterobacteriaceae.
Institute:University of British Columbia
Last Name:Finlay
First Name:Brett
Address:office: MSL 333 lab: MSL 363
Email:bfinlay@interchange.ubc.ca
Phone:604-822-2210
Funding Source:Canadian Institutes of Health Research (CIHR) [FDN-159935] and Genome Canada/Genome BC (264PRO)

Subject:

Subject ID:SU003482
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Species Group:Mammals

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Time point Treatment Sample source
SA365865A9Day 0 Chol Feces
SA365866A12Day 0 Chol Feces
SA365867A11Day 0 Chol Feces
SA365868A10Day 0 Chol Feces
SA365869A7Day 0 Chol Feces
SA365870A8Day 0 Chol Feces
SA365871A2Day 0 Con Feces
SA365872A1Day 0 Con Feces
SA365873A6Day 0 Con Feces
SA365874A4Day 0 Con Feces
SA365875A5Day 0 Con Feces
SA365876A3Day 0 Con Feces
SA365877C8Day 14 Chol Feces
SA365878C12Day 14 Chol Feces
SA365879C11Day 14 Chol Feces
SA365880C10Day 14 Chol Feces
SA365881C9Day 14 Chol Feces
SA365882C7Day 14 Chol Feces
SA365883C6Day 14 Con Feces
SA365884C5Day 14 Con Feces
SA365885C4Day 14 Con Feces
SA365886C3Day 14 Con Feces
SA365887C2Day 14 Con Feces
SA365888C1Day 14 Con Feces
SA365889D8Day 21 Chol Feces
SA365890D12Day 21 Chol Feces
SA365891D11Day 21 Chol Feces
SA365892D10Day 21 Chol Feces
SA365893D9Day 21 Chol Feces
SA365894D7Day 21 Chol Feces
SA365895D6Day 21 Con Feces
SA365896D5Day 21 Con Feces
SA365897D4Day 21 Con Feces
SA365898D1Day 21 Con Feces
SA365899D2Day 21 Con Feces
SA365900D3Day 21 Con Feces
SA365901E7Day 28 Chol Feces
SA365902E8Day 28 Chol Feces
SA365903E9Day 28 Chol Feces
SA365904E10Day 28 Chol Feces
SA365905E11Day 28 Chol Feces
SA365906E12Day 28 Chol Feces
SA365907E1Day 28 Con Feces
SA365908E2Day 28 Con Feces
SA365909E3Day 28 Con Feces
SA365910E4Day 28 Con Feces
SA365911E6Day 28 Con Feces
SA365912E5Day 28 Con Feces
Showing results 1 to 48 of 48

Collection:

Collection ID:CO003475
Collection Summary:Feces were collected aseptically from 4-8 wks old mice. Briefly, mice were placed in an empty autoclaved cage without bedding. Mice were then allowed to defecate normally and the first two fecal pellets were collected using sterile forceps, followed by snap freezing in liquid nitrogen. For processing, feces were homogenized in 100% methanol (50 mg/mL) and spun (13,500 rpm, 10 mins) to collect BA-containing supernatant.
Sample Type:Feces

Treatment:

Treatment ID:TR003491
Treatment Summary:Female C57BL/6 mice (4 weeks old; The Jackson Laboratory) were randomized and then, reared and maintained on control (Con) or 2% cholestyramine diets (Chol; D18062501I and D22112802I, respectively; Research Diets Inc.) until the end of the experiment. Fecal BA levels were quantified using mass spectrometer as described below. BA levels at the end of 4 weeks on diet were normalized to baseline BA levels (day 0) and represented as absolute intensity.

Sample Preparation:

Sampleprep ID:SP003489
Sampleprep Summary:Murine feces were homogenized in 100% methanol (50 mg/mL) and spun (13,500 rpm, 10 mins) to collect BA-containing supernatant. Extracted samples were resuspended using 100% methanol before LC-MS analysis.

Combined analysis:

Analysis ID AN005503
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Vanquish
Column Waters ACQUITY UPLC CSH C18 (150 x 2.1mm,1.7um)
MS Type ESI
MS instrument type QTOF
MS instrument name Bruker Impact II
Ion Mode NEGATIVE
Units Relative abundance

Chromatography:

Chromatography ID:CH004185
Chromatography Summary:A longer ACQUITY UPLC CSH C18 analytical column (130Å, 1.7 µm, 2.1 mm X 150 mm, Waters) was used to achieve chromatographic separation, with a multistep elution gradient.
Instrument Name:Thermo Vanquish
Column Name:Waters ACQUITY UPLC CSH C18 (150 x 2.1mm,1.7um)
Column Temperature:65
Flow Gradient:0 min 30% B, 2.5 min 30% B, 10 min 55% B, 11 min 99%B, 13min 99% B, 13.5 min 30% B, 17 min 30% B
Flow Rate:0.35 mL/min
Solvent A:100% water; 0.1% formic acid
Solvent B:100% acetonitrile; 0.1% formic
Chromatography Type:Reversed phase

MS:

MS ID:MS005229
Analysis ID:AN005503
Instrument Name:Bruker Impact II
Instrument Type:QTOF
MS Type:ESI
MS Comments:To ensure strict quality control and evaluate the performance of the instrument, 20 µL aliquots were taken from each individual sample and combined to form a quality control sample (QC). This QC sample was then injected after every five samples, which helped in assessing the stability of the instrument and the coefficient of variation (CV) associated with the detected ions. Raw data processing was performed using Progenesis QI™ software (V3.0.7600.27622) incorporating METLIN™ plugin V1.0.7642.33805 (NonLinear Dynamics, Newcastle Upon Tyne, UK). This included peak picking, alignment, normalization and integration. Statistical analysis was performed using peak area.
Ion Mode:NEGATIVE
  logo